본문 바로가기
KERD
논문KCI 등재

Protective Effect of Ultra Low Molecular Weight Heparin on Glutamate-Induced Apoptosis in Cortical Cells

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류의학일반

초록

Purpose: To investigate the effect of ultra low molecular weight heparin (ULMWH) on glutamate induced apoptosis in rat cortical cells and to explore the possible mechanisms. Materials and Methods: Cell viability was measured using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Apoptosis was first analyzed with Hoechst 33258 and then confirmed by DNA fragmentation. The concentration of free intracellular calcium ([Ca²+]i) was determined with fura-2/AM fluorometry. The expression of Bcl-2 family protein and caspase-3 were evaluated with Western blot. Results: Typical apoptotic morphological change in rat cortical cells treated with 100μmol/L glutamate for 24h was detected by Hoechst 33258 staining, which was then confirmed by the DNA ladder of agarose gel electrophoresis. The apoptotic rate of the glutamate treated cells was up to 33.21%, and 24 h of treatment with glutamate increased [Ca²+]i, down-regulated Bcl-2 expression, up-regulated Bax expression, and increased caspase-3 activation in rat cortical cells. Our research demonstrated that ULMWH pretreatment can prevent the glutamate- induced apoptosis, attenuate the increase of [Ca²+]i not only in medium containing Ca²+ but also in Ca²+-free medium, up-regulate the expression of Bcl-2, down-regulate the expression of Bax, and decrease caspase-3 activation. Conclusion: ULMWH has neuroprotective capacity to antagonize glutamate-induced apoptosis in cortical cells, through decrease of Ca²+ release and modulation of apoptotic processes.

Abstract

Purpose: To investigate the effect of ultra low molecular weight heparin (ULMWH) on glutamate induced apoptosis in rat cortical cells and to explore the possible mechanisms. Materials and Methods: Cell viability was measured using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Apoptosis was first analyzed with Hoechst 33258 and then confirmed by DNA fragmentation. The concentration of free intracellular calcium ([Ca²+]i) was determined with fura-2/AM fluorometry. The expression of Bcl-2 family protein and caspase-3 were evaluated with Western blot. Results: Typical apoptotic morphological change in rat cortical cells treated with 100μmol/L glutamate for 24h was detected by Hoechst 33258 staining, which was then confirmed by the DNA ladder of agarose gel electrophoresis. The apoptotic rate of the glutamate treated cells was up to 33.21%, and 24 h of treatment with glutamate increased [Ca²+]i, down-regulated Bcl-2 expression, up-regulated Bax expression, and increased caspase-3 activation in rat cortical cells. Our research demonstrated that ULMWH pretreatment can prevent the glutamate- induced apoptosis, attenuate the increase of [Ca²+]i not only in medium containing Ca²+ but also in Ca²+-free medium, up-regulate the expression of Bcl-2, down-regulate the expression of Bax, and decrease caspase-3 activation. Conclusion: ULMWH has neuroprotective capacity to antagonize glutamate-induced apoptosis in cortical cells, through decrease of Ca²+ release and modulation of apoptotic processes.

참고문헌 (50)

  1. Bergamaschini L, "Peripheral treatment with enoxaparin, a low molecular weight heparin, reduces plaques and beta-amyloid accumulation in a mouse model of Alzheimer's disease", J Neurosci, 24, pp.4181~4186 (2004)
  2. Zhu H, "Inhibition of amyloidosis using low-molecular-weight heparins", Mol Med, 7, pp.517~522 (2001)
  3. Jonas S, "Is low molecular weight heparin a neuroprotectant?", Ann N Y Acad Sci, 825, pp.389~393 (1997)
  4. Ma Q, "The blood-brain barrier accessibility of a heparin-derived oligosaccharides C3", Thromb Res, 105, pp.447~453 (2002)
  5. Zhang ZG, "Antagonistic effects of ultra-low-molecular-weight heparin against cerebral ischemia", reperfusion injury in rats, 2007, pp.56, 350~355
  6. Duarte AI, "Insulin neuroprotection against oxidative stress in cortical neurons-involvement of uric acid and glutathione antioxidant defenses", Free Radic Biol Med, 39, pp.876~889 (2005)
  7. Mosmann T, "Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays", J Immunol Methods, 65, pp.55~63 (1983)
  8. Cavaliere F, "Hypoglycaemia-induced cell death: features of neuroprotection by the P2 receptor antagonist basilen blue", Neurochem Int, 38, pp.199~207 (2001)
  9. Wolozin B, "Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation", Science, 274, pp.1710~1713 (1996)
  10. Grynkiewicz G, "A new generation of Ca2+ indicators with greatly improved fluorescence properties", J Biol Chem, 260, pp.3440~3450 (1985)
  11. Sur P, "Estrogen attenuates oxidative stress-induced apoptosis in C6 glial cells", Brain Res, 971, pp.178~188 (2003)
  12. Bleich S, "Glutamate and the glutamate receptor system: a target for drug action", Int J Geriatr Psychiatry, 18(1), pp.s33~s40 (2003)
  13. Conn PJ, "Physiological roles and therapeutic potential of metabotropic glutamate receptors", Ann N Y Acad Sci, 1003, pp.12~21 (2003)
  14. Spillson AB, "Metabotropic glutamate receptor regulation of neuronal cell death", Exp Neurol, 184(1), pp.s97~s105 (2003)
  15. Mori H, "Roles of diverse glutamate receptors in brain functions elucidated by subunit-specific and region-specific gene targeting", Life Sci, 74, pp.329~336 (2003)
  16. Huettner JE, "Kainate receptors and synaptic transmission", Prog Neurobiol, 70, pp.387~407 (2003)
  17. Manev H, "Delayed increase of Ca2+ influx elicited by glutamate: role in neuronal death", Mol Pharmacol, 36, pp.106~112 (1989)
  18. Naarala JT, "Lead amplifies glutamate-induced oxidative stress", Free Radic Biol Med, 19, pp.689~693 (1995)
  19. Ankarcrona M, "Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function", Neuron, 15, pp.961~973 (1995)
  20. Choi DW, "Ionic dependence of glutamate neurotoxicity", Neurosci, 7, pp.369~379 (1987)
  21. Koh JY, "Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage", Brain Res, 533, pp.315~320 (1990)
  22. Smith T, "Autoimmune encephalomyelitis ameliorated by AMPA antagonists", Nat Med, 6, pp.62~66 (2000)
  23. Turski L, "Protection of substantia nigra form MPP+ neurotoxicity by N-methyl-D-aspartate antagonists", Nature, 349, pp.414~418 (1991)
  24. Matsuzaki H, "Activation of Akt kinase inhibits apoptosis and changes in Bcl-2 and Bax expression induced by nitric oxide in primary hippocampal neurons", J Neurochem, 73, pp.2037~2046 (1999)
  25. Choi DW, "The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death", Annu Rev Neurosci, 13, pp.171~182 (1990)
  26. Kristián T, "Calcium-related damage in ischemia", Life Sci, 59, pp.357~367 (1996)
  27. Nishizawa Y, "Glutamate release and neuronal damage in ischemia", Life Sci, 69, pp.369~381 (2001)
  28. Vaux DL, "Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells", Nature, 335, pp.440~442 (1988)
  29. Ghosh TK, "Competitive, reversible, and potent antagonism of inositol 1,4,5-trisphosphate-activated calcium release by heparin", J Biol Chem, 263, pp.11075~11079 (1988)
  30. Cullen PJ, "Heparin inhibits the inositol 1,4,5-trisphosphate-induced Ca2+ release from rat liver microsomes", FEBS Lett, 228, pp.57~59 (1988)
  31. Berridge MJ, "Inositol trisphosphate and calcium signalling", Nature, 361, pp.315~325 (1993)
  32. Trump BF, "Calcium-mediated cell injury and cell death", FASEB J, 9, pp.219~228 (1995)
  33. Pasquet JM, "Calcium influx is a determining factor of calpain activation and microparticle formation in platelets", Eur J Biochem, 239, pp.647~654 (1996)
  34. Merry DE, "Bcl-2 gene family in the nervous system", Annu Rev Neurosci, 20, pp.245~267 (1997)
  35. Staunton MJ, "Apoptosis: basic concepts and potential significance in human cancer", Arch Pathol Lab Med, 122, pp.310~319 (1998)
  36. Korsmeyer SJ, "Bcl-2 initiates a new category of oncogenes: regulators of cell death", Blood, 80, pp.879~886 (1992)
  37. Haunstetter A, "Apoptosis: basic mechanisms and implications for cardiovascular disease", Circ Res, 82, pp.1111~1129 (1998)
  38. Kajstura J, "Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats", Lab Invest, 74, pp.86~107 (1996)
  39. Oltvai ZN, "Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death", Cell, 74, pp.609~619 (1993)
  40. Huang Q, "Immunohistochemical analysis of Bcl-2 and Bax oncoproteins in rabbit craniomandibular joint", Arch Oral Biol, 49, pp.143~148 (2004)
  41. Eves EM, "Akt, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line", Mol Cell Biol, 18, pp.2143~2152 (1998)
  42. Zhong LT, "Bcl-2 blocks glutamate toxicity in neural cell lines", Brain Res Mol Brain Res, 19, pp.353~355 (1993)
  43. Thornberry NA, "Caspases: enemies within", Science, 281, pp.1312~1316 (1998)
  44. Yang JN, "Caspases promoted DADAG-induced apoptosis in human leukemia HL-60 cells", Acta Pharmacol Sin, 23, pp.461~466 (2002)
  45. Daniel PT, "Dissecting the pathways to death", Leukemia, 14, pp.2035~2044 (2000)
  46. Kluck RM, "The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis", Science, 275, pp.1132~1136 (1997)
  47. Chen J, "Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia", J Neurosci, 18, pp.4914~4928 (1998)
  48. Annunziato L, "Apoptosis induced in neuronal cells by oxidative stress: role played by caspases and intracellular calcium ions", Toxicol Lett, 139, pp.125~133 (2003)
  49. Hills FA, "Heparin prevents programmed cell death in human trophoblast", Mol Hum Reprod, 12, pp.237~243 (2006)
  50. Deepa PR, "Influence of a low-molecular- weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity", Toxicology, 217, pp.176~183 (2006)

관련 논문AI추천

이 간행물의 다른 논문 (12건)